Applications for the 2021 British Skin Foundation National Keratinocyte Cancer Research Award are now closed.

All applications submitted after Sunday 31st October, 23:59 GMT were not considered. Eligible applications are forwarded to the Grants Advisory Committee towards the end of the year, with applicants then being notified via email by early January, 2022.

For all general enquiries regarding BSF grants, please contact [email protected]


About the award

The British Skin Foundation is offering a £300,000, three-year initial grant fund for the pilot phase to facilitate the development of a national research collaborative on keratinocyte cancer. To achieve this, two key areas will be undertaken: tissue banking and molecular pathology.

The overall project should align with the British Association of Dermatologist’s (BAD) aims to improve clinical outcomes for the care of patients with keratinocyte cancers. Its key objectives are to support epidemiology work on keratinocyte cancer, to better understand the molecular pathogenesis of cutaneous squamous cell carcinoma (CSCC) and to create a biorepository of tissue samples. The BAD's ambition is that the outcome of this project will create a collaboration that provides national coverage, and generates a research resource accessible to all BAD members. 

Applications are sought from UK academic centres and clinical involvement from the UK Dermatology Community is encouraged.  The study must include a research question of national importance to the NHS, so that the project will be eligible for the NIHR portfolio.  It should be multi-centred at the outset with the potential to expand.   The BAD’s resources and experience at managing industry contracts for the benefit of research projects will also be available to the successful centre. The grant applicant must demonstrate how the project will evolve beyond the initial set up phase, with a long-term vision for future sustainability.

This grant has been made possible by a generous donation from the British Association of Dermatologists (BAD), who will be one of the collaborators in this project. There is an expectation that the project will be self-sufficient past the initial funding period. The winner of the grant funding will work with the BAD to develop this project further.

Supporting Documents